Furthermore, MSI1 inhibits miR-671-5p suppression of TNF receptor-associated factor 2 (TRAF2) to induce CSC characteristics and tumor invasion and silence signal transducer and activator of transcription 3 (STAT3) to enhance radioresistance in GBM. This evidence concerns the gene TRAF2 and glioblastoma.